You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice

 

Online download statistics by month:

Online download statistics by month: March 2023 to April 2026

AbstractFullPdf
Mar 202318941913377
Apr 2023738743175
May 2023416419119
Jun 202327327694
Jul 202321421690
Aug 202321121574
Sep 202317117160
Oct 202318418575
Nov 202322322589
Dec 202316716993
Jan 2024183185100
Feb 2024239243113
Mar 2024310316206
Apr 2024272273150
May 2024312313139
Jun 2024201201130
Jul 2024231232128
Aug 202415315187
Sep 2024212215122
Oct 2024253256137
Nov 2024243245157
Dec 2024329345124
Jan 2025294295170
Feb 2025419424175
Mar 2025342346173
Apr 2025521522181
May 2025284288180
Jun 2025231232113
Jul 2025220
Apr 2026110
Total952396173831